DeepMed Research

The University Of Texas Health Science Center At San Antonio

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Demonstration of a Novel Approach Using Surface-Image Guidance to Improve Delivery of Breast Radiotherapy

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Temporary skin markings
Other: Surface imaging

First Posted Date: 2019-01-10

Last Posted Date: 2024-08-09

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 75

Registration Number: NCT03799523

Locations: 🇺🇸
UT Health San Antonio Mays Cancer Center, San Antonio, Texas, United States

Placement of Antibiotic Powder in Wounds During the Emergency Room

Phase 4

Recruiting

Conditions: Open Fracture

Interventions: Drug: Vancomycin

First Posted Date: 2018-12-05

Last Posted Date: 2024-07-29

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 200

Registration Number: NCT03765567

Locations: 🇺🇸
University Hospital, San Antonio, Texas, United States
🇺🇸
San Antonio Military Medical Center, San Antonio, Texas, United States

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Phase 2

Active, not recruiting

Conditions: Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Pancreatic Ductal Adenocarcinoma

Interventions: Drug: Pembrolizumab
Drug: Defactinib

First Posted Date: 2018-11-01

Last Posted Date: 2025-05-04

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 36

Registration Number: NCT03727880

Locations: 🇺🇸
The University of Texas Health Science Center San Antonio, San Antonio, Texas, United States
🇺🇸
Samuel Oschin Cancer Center at Cedars-Sinai, Los Angeles, California, United States
🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Impact of Metformin on Immunity

Phase 1

Completed

Conditions: Aging
Vaccine Response Impaired

Interventions: Drug: Placebo
Drug: Metformin

First Posted Date: 2018-10-22

Last Posted Date: 2024-08-20

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 18

Registration Number: NCT03713801

Locations: 🇺🇸
UT Health San Antonio, San Antonio, Texas, United States

Network Dysregulation Among Individuals With Comorbid Tinnitus and PTSD

Not Applicable

Completed

Conditions: Stress Disorders, Post-Traumatic
Tinnitus

Interventions: Behavioral: Cognitive Processing Therapy (CPT)

First Posted Date: 2018-10-10

Last Posted Date: 2021-05-26

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 10

Registration Number: NCT03702166

Locations: 🇺🇸
UT Health San Antonio, San Antonio, Texas, United States

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Recruiting

Conditions: Lung Neoplasm

First Posted Date: 2018-08-31

Last Posted Date: 2025-01-07

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 150

Registration Number: NCT03655015

Locations: 🇺🇸
UT Health San Antonio, M.D. Anderson Cancer Center, San Antonio, Texas, United States

Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants

Not Applicable

Completed

Conditions: Drunk Driving

Interventions: Behavioral: Contingency Management
Behavioral: Control

First Posted Date: 2018-08-20

Last Posted Date: 2024-05-07

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 158

Registration Number: NCT03638596

Locations: 🇺🇸
University of Texas Health Science Center San Antonio, San Antonio, Texas, United States

Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron

Early Phase 1

Completed

Conditions: Cognitive Change
Spinal Cord Injuries
Neurogenic Bladder

Interventions: Drug: Mirabegron

First Posted Date: 2018-08-02

Last Posted Date: 2021-06-22

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 20

Registration Number: NCT03612401

Locations: 🇺🇸
South Texas Veterans Health Care System, Audie L. Murphy Hospital, San Antonio, Texas, United States

Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1

Phase 1

Recruiting

Conditions: Heart Failure
Type 2 Diabetes Mellitus

Interventions: Drug: Beta-hydroxy-butyrate

First Posted Date: 2018-06-18

Last Posted Date: 2025-01-31

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 78

Registration Number: NCT03560323

Locations: 🇺🇸
Texas Diabetes Institute - University Health System, San Antonio, Texas, United States
🇺🇸
University of Texas Health Science Center San Antonio, San Antonio, Texas, United States

Project Remission: Maximizing Outcomes With Intensive Treatments for Combat-Related PTSD

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorder (PTSD)

Interventions: Behavioral: Massed Prolonged Exposure
Behavioral: Intensive Outpatient Prolonged Exposure

First Posted Date: 2018-05-18

Last Posted Date: 2022-08-08

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 234

Registration Number: NCT03529435

Locations: 🇺🇸
Brooke Army Medical Center, San Antonio, Texas, United States
🇺🇸
Carl R. Darnall Army Medical Center, Fort Hood, Texas, United States
🇺🇸
South Texas Veterans Health Care System, San Antonio, Texas, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy